Navigation Links
UC Riverside's new state-of-the-art technology to accelerate stem cell research
Date:2/2/2010

RIVERSIDE, Calif. Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories.

The SCCF, located in Noel Keen Hall, had its grand opening on Friday, Jan. 29.

More than 200 visitors from all over Southern California attended the celebration that included tours of the Core labs, demonstrations of the facility's new equipment, posters on stem cell research being done at UCR, information on how to get started in stem cell research, and contests with prizes for the best posters and images. Several vendors demonstrated their products related to stem cell research.

"We are the only such core facility in the Inland Empire," said Prue Talbot, the director of the Stem Cell Center and the SCCF. "Such a facility is needed on campus to give an opportunity to UCR researchers who are interested in doing stem cell research but who don't have a facility for it. The facility also greatly benefits labs on campus that are already doing research on stem cells but that lack the expensive equipment the SCCF has to offer."

The SCCF was funded primarily by a grant from the California Institute for Regenerative Medicine. The $2.8 million grant helped construct the 2000-square-foot facility, purchase state-of-the-art equipment, and manage day-to-day operations.

Talbot expects the SCCF to produce breakthroughs in stem cell research at a much faster pace than before, assisted by its Nikon BioStation CT incubator with a powerful microscope that already has generated useful data in conjunction with video bioinformatics. UCR is the first institution in the country to purchase the Nikon BioStation CT technology.

"The BioStation technology coupled with UCR's expertise in video bioinformatics will greatly facilitate our ability to understand dynamic cell processes and will provide data essential for attacking degenerative disease," Talbot said. "Faculty planning on using this instrument and other Core facilities have interests in osteoporosis, diabetes, wound healing, neurodegeneration and brain damage, and infertility. UCR also has labs that use BioStation technology to prevent disease by identifying environmental toxicants before they can harm humans."

Approximately 10 laboratories on campus will use the SCCF. The facility is open also to scientists not at UCR. Users will be recharged for supplies at a fair price.


'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Related biology news :

1. New Singapore-France research alliance to develop state-of-the-art nanotechnologies
2. Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning
3. G. Unger Vetlesen Foundation funds purchase of state-of-the-art equipment for UMs Rosenstiel School
4. New manual presents robust, state-of-the-art proteomics methods for teaching and research
5. NIH awards more than $33 million to fund state-of-the-art research equipment
6. TGen becomes center of excellence for Horizon Discoverys GENESIS and X-MAN technology
7. Engineers explore environmental concerns of nanotechnology
8. Conference to discuss future of nanotechnology enabled sensors
9. Global warming and other environmental dangers may be solved by unlikely source -- space technology
10. GE Healthcare to evaluate and develop novel imaging technology
11. Novel nanotechnology heals abscesses caused by resistant staph bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC Riverside's new state-of-the-art technology to accelerate stem cell research
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology: